Paxman ABPXMBF 77 Days Inventory is 106.51 as of Mar. 2026, which is 38% below its 10-year median of 170.78. GuruFocus rates PXMBF with a GF Score™ of 77/100 and a GF Value™ of $4.38. The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Paxman AB ranks better than 78.88% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Paxman AB's Average Total Inventories for the
three
months ended in Mar. 2026 was $3.77 Mil. Paxman AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $3.23 Mil.
Hence, Paxman AB's Days Inventory for the
three
months ended in Mar. 2026 was 106.51.
The historical rank and industry rank for Paxman AB's Days Inventory or its related term are showing as below:
PXMBF'
s Days Inventory Range Over the Past 10 Years
Min: 105.81 Med: 170.78 Max: 517.96
Current: 105.81
During the past 9 years, Paxman AB's highest Days Inventory was 517.96. The lowest was 105.81. And the median was 170.78.
PXMBF's Days Inventory is ranked better than 78.88% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs PXMBF: 105.81
Paxman AB's Days Inventory
declined
from Mar. 2025 (112.67) to Mar. 2026 (106.51).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Paxman AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.86.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Paxman AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.39.
Paxman AB (OTCPK:PXMBF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Paxman AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Paxman AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Paxman AB Days Inventory Related Terms
Paxman AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Paxman AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Paxman AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paxman AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Paxman AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paxman AB (PXMBF) has a Days Inventory of 106.51 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Paxman AB and its competitors. This is 38% below median its historical median of 170.78. Over the past decade, Paxman AB's Days Inventory has ranged from 105.81 to 517.96. According to the industry distribution chart, Paxman AB ranks #166 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 21.1%.
Is Paxman AB's Days Inventory too high?
Paxman AB's current Days Inventory of 106.51 is 38% below median its 10-year median of 170.78. Over the past 10 years, this metric has ranged from a low of 105.81 to a high of 517.96. The Medical Devices & Instruments industry median Days Inventory is 179.60. Paxman AB's value of 106.51 is 40.7% below this industry median. Based on the distribution chart, Paxman AB ranks #166 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Paxman AB has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Paxman AB's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Paxman AB ranks #166 out of 786 companies for Days Inventory. This places Paxman AB in the top 21% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. Paxman AB's value of 106.51 is 40.7% below this benchmark. Historically, Paxman AB's own Days Inventory has ranged from 105.81 to 517.96 over the past decade. While the company's 10-year median is 170.78 vs. the industry median of 179.60, Paxman AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paxman AB's current Days Inventory of 106.51 is 40.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Paxman AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paxman AB's current Days Inventory is 106.51, which is 38% below median its own 10-year median of 170.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paxman AB stock overvalued right now?
Paxman AB (PXMBF) has a current Days Inventory of 106.51. The stock's GF Value™ is $4.38, compared to a current price of $3.50 — trading 20.1% below its estimated fair value. The current Days Inventory is 106.51, which is 38% below median its 10-year median of 170.78 and 40.7% below the Medical Devices & Instruments industry median of 179.60. Paxman AB's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Paxman AB (PXMBF), the current Days Inventory is 106.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paxman AB (PXMBF) Overvalued in 2026?
Based on GuruFocus' analysis, Paxman AB stock appears to be undervalued.
The current stock price of $3.50 is trading 20.1% below its estimated GF Value™ of $4.38.
Key valuation signals for PXMBF:
Days Inventory: 106.51 (38% below median its 10-year median of 170.78)
GF Value™: $4.38 vs. price of $3.50 (20.1% below fair value)
Industry Position: 40.7% below the Medical Devices & Instruments median (#166 of 786)
No single metric tells the full story. See the PXMBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.
77GF Score
Get the complete analysis for PXMBF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PXMBF has been successfully added to your 
